Hims Stock: Leading the Charge in Global Digital Health Expansion

US Stocks

Hims & Hers Health, Inc. stands out in the digital health world, and its stock, known as Hims stock, grabs attention on the stock market. Founded in 2017 and trading publicly since January 2021, the company has seen its shares soar 96.8% this year and 134% over the past 12 months. Yet, a 35% drop one day earlier in 2025 shows that growth comes with ups and downs.

The big news is the company’s push to grow worldwide, especially with its June 2025 purchase of ZAVA, a major European health platform. ZAVA handled 2.3 million consultations in 2024, adding 1.3 million active users to Hims’ stock value.

This move, plus plans to enter Canada, positions Hims as a leader in global health solutions.

Why Hims Stock Stands Out in Digital Health

Hims stock reflects a company that’s changing how people get healthcare. Hims & Hers connects users to doctors online, offering help for hair loss, mental health, and weight loss. Its growth shows in the numbers: shares jumped 96.8% in 2025 so far.

The stock market loves this kind of progress, but that 35% plunge reminds us of the risks. Hims keeps pushing forward, focusing on easy, personal care that people want. That’s why investors keep an eye on Hims stock.

Hims Stock
Hims & Hers Health, Inc. (HIMS) Stock Chart 

The ZAVA Acquisition Boosts Global Reach

  • In June 2025, Hims acquired ZAVA, a European digital health platform.
  • ZAVA handled 2.3 million consultations in 2024 and brought 1.3 million new users to Hims.
  • The acquisition expands Hims’ presence in the UK, Germany, and other European markets.
  • The deal boosts investor appeal, making Hims stock more attractive.
  • It’s a strategic response to strained European health systems, offering quick, online care.
  • Hims expects the acquisition to increase profits by 2026.

What ZAVA Brings to Hims

ZAVA isn’t a small player. Here’s what it adds to Hims:

  1. Huge User Base: 1.3 million active customers join Hims overnight.
  2. Experience: 2.3 million consultations show ZAVA knows digital health.
  3. Local Fit: Hims can now offer care in local languages across Europe.
Hims Stock
Image Source: Zacks Investment Research

Financial Power Behind Hims Stock

Money talks, and Hims’ stock has a strong story. Experts at Zacks predict a 177.8% earnings jump in 2025, with earnings per share hitting $0.75. That’s up $0.02 from earlier guesses.

For the next earnings on August 4, 2025, analyst Jailendra Singh sees $549.4 million in revenue and $74.4 million in adjusted EBITDA. These numbers show Hims thrives in a busy stock market.

Key Numbers to Know

Here’s a quick look at Hims’ financial health:

Hims Stock

Hims Stock in the Growing Health Industry

Digital health is booming, and Hims stock rides the wave. The market hit $288.55 billion in 2024 and could grow 22.2% yearly through 2030, says Grand View Research. Hims fits right in with its online doctor visits.

Other companies, like Teladoc with its Catapult Health buy, compete too. But Hims’ focus on personal care and new markets keeps it ahead in the stock market.

What Analysts Say

Analysts have mixed views on Hims’ stock. The average price target is $41.78, hinting at a 17% drop in the next year. That caution comes after the 35% fall in 2025.

Still, Hims looks solid compared to rivals. Its price-to-sales ratio of 4.4 beats Teladoc’s 0.6, showing Hims offers growth value in the stock market.

Final Thoughts

Hims stock shines as a leader in digital health, thanks to smart moves like buying ZAVA. Its growth in users and revenue keeps it strong in the stock market. Investors should watch its next steps closely.

Disclaimer:

This content is for informational purposes only and not financial advice. Always conduct your research.